EFTA01014572.pdf

From: J [email protected]> To: Subject: Re: Date: Mon, 03 Dec 2018 13:18:04 +0000 On Mon, Dec 3, 2018 at 8:13 AM Church, George < > wrote: I enjoyed the conversation too. Thanks for asking about the 27 cos. Most of these are either very young newcos (15 in 2018) or I had minor/diluted shares. Also payback in biotech is slower than most investments. Even though my Harvard lab is very frugal (reducing costs by 10 million-fold), and most our 90 employees get paid less than $60K per year, we still have many good ideas that don't get implemented. Also, last week I learned that our largest and longest grant won't be renewable for the very odd reason that we have been too successful in peer-review. A few members of Congress 'might' be looking for examples of 'Center of Excellence' teams that are getting money year after year. (Sounds like Harrison Bergeron). The administrators are afraid that one successful lab could endanger many other grants (or even their whole program). They aren't even that sure about the Congressional concern rumor, but this is still enough to derail my lab renewal. Thanks again. --George From: "jeffrey E." <[email protected]> Date: Monday, December 3, 2018 at 5:01 AM To: George Church cl lots of fun yesterday , thx for coming . I was surprised to hear that with 27 cos formed you were stil concerned about money? . would you ikke the share the details of the situation? to see if i can be helpful please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of WE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited EFTA01014572  and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA01014573